Osteoarthritis Trial, Recruiting (NCT02993029)

Osteoarthritis Trial, Recruiting NCT02993029 Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT02993029 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have osteoarthritis that causes pain.
People whose affected knee shows a specific level of bone activity (a measurement called SUV greater than 10) on a special type of bone scan using a substance called 18F-sodium fluoride.
People who are willing to take part voluntarily and have signed a consent form agreeing to participate.

Who may not be able to join:

People who have had a knee joint replacement.
People who have an inflammatory type of arthritis (such as rheumatoid arthritis) or an active joint infection in the knee.
People who have a nerve-related joint condition (sometimes called neuropathic joint disease) (confirm with trial site).
People who have a fracture (broken bone) in or around the joint.
People who have gout affecting the knee.
People whose arthritis was caused by a physical injury or trauma.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhongwei Lv, MD, The 10th Hospital, Tongji University

Phone: +86-021-25078593

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02993029

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: +86-021-25078593

More information: https://clinicaltrials.gov/study/NCT02993029

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have osteoarthritis that causes pain.
People whose affected knee shows a specific level of bone activity (a measurement called SUV greater than 10) on a special type of bone scan using a substance called 18F-sodium fluoride.
People who are willing to take part voluntarily and have signed a consent form agreeing to participate.

Who may not be able to join:

People who have had a knee joint replacement.
People who have an inflammatory type of arthritis (such as rheumatoid arthritis) or an active joint infection in the knee.
People who have a nerve-related joint condition (sometimes called neuropathic joint disease) (confirm with trial site).
People who have a fracture (broken bone) in or around the joint.
People who have gout affecting the knee.
People whose arthritis was caused by a physical injury or trauma.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Registry

ClinicalTrials.gov

Start date

1 September 2017

Est. completion

30 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

pain, stiffness and joint function of knee

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov